Niket Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Niket Shah has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Mahesh Goel
Department of Surgical Oncology Tata Memorial Hospital and Homi Bhabha National Institution Mumbai India
3 shared publications Gurudutt P. Varty
Hepatopancreatobiliary Division of Department of Surgical Oncology Tata Memorial Hospital Mumbai India
2 shared publications- Kaival Gundavda
Hepatopancreatobiliary Division of Department of Surgical Oncology Tata Memorial Hospital Mumbai India
2 shared publications Shraddha Patkar
Tata Memorial Hospital, Mumbai, India
2 shared publications- Ajay Gulati
Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
1 shared publication - Amit Choudhari
Tata Memorial Hospital, Mumbai, India
1 shared publication
Latest Publications
- 9 October 2026
- Published by Wiley in World Journal of Surgery
Defining the Role of Staging Laparoscopy in the Management of the Gallbladder Cancers: A Single Institution Experience
Introduction: Despite advances in imaging and extensive staging work‐up, occult metastases may still be encountered at laparotomy in patients with apparently resectable gallbladder cancer (GBC), resulting in nontherapeutic surgery. This study evaluates the incremental yield of staging laparoscopy (SL) in detecting radiologically occult metastases in resectable GBC and its role in routine staging. Methods: A prospectively maintained database of patients operated for GBC at a high volume institution was analyzed to calculate the diagnostic yield of SL and the percentage of missed metastases by modern imaging analysis but subsequently diagnosed on SL. In the univariate and multivariate logistic regression, the following binary variables were evaluated to identify predictors of metastasis on SL: (i) NACT (neoadjuvant chemotherapy) receipt: yes versus no; (ii) serum carbohydrate antigen 19–9 (CA19‐9) level: > 1000 u/mL versus ≤ 1000 U/mL; (iii) 18 fluorodeoxyglucose positron emission tomography/computed tomography ( 18 FDG PET/CT) scan result: equivocal versus negative (positive results were excluded from this analysis as they would not have proceeded to SL without additional workup); (iv) clinical stage: locally advanced versus early; (v) incidental GBC: yes versus no; (vi) tumor grade: moderate/poorly differentiated versus well differentiated. Results: The SL was incorporated into the diagnostic and management pathway of 330 GBC patients. SL was performed (i) as a staging prior to a planned radical cholecystectomy ( n = 210, 63.6%) and (ii) prior to initiating systemic therapy ( n = 120, 36.4%). The diagnostic yield of SL for detection of metastases over cross‐sectional imaging was 11.5% ( n = 38). Reasons for inoperability on laparotomy were metastatic 16b1 lymph node (LN) ( n = 19, 50%), locally unresectable disease ( n = 15, 39.5%), peritoneal metastasis ( n = 2, 5.3%), and liver metastasis ( n = 2, 5.3%). The reason for locally unresectable disease was right hepatic artery encasement at the porta hepatis. Regression analysis showed that the significant predictors for metastatic disease on SL were equivocal uptake on 18 FDG PET/CT scan ( p = < 0.001) and prior NACT ( p = 0.026). Conclusion: SL provides an incremental detection of radiologically occult metastasis in up to 11.5% patients. The study underscores the benefit of SL and suggests that it should be incorporated in the management of all GBC patients.
- 9 October 2026
- Published by Wiley in World Journal of Surgery
Defining the Role of Staging Laparoscopy in the Management of the Gallbladder Cancers: A Single Institution Experience
Introduction: Despite advances in imaging and extensive staging work‐up, occult metastases may still be encountered at laparotomy in patients with apparently resectable gallbladder cancer (GBC), resulting in nontherapeutic surgery. This study evaluates the incremental yield of staging laparoscopy (SL) in detecting radiologically occult metastases in resectable GBC and its role in routine staging. Methods: A prospectively maintained database of patients operated for GBC at a high volume institution was analyzed to calculate the diagnostic yield of SL and the percentage of missed metastases by modern imaging analysis but subsequently diagnosed on SL. In the univariate and multivariate logistic regression, the following binary variables were evaluated to identify predictors of metastasis on SL: (i) NACT (neoadjuvant chemotherapy) receipt: yes versus no; (ii) serum carbohydrate antigen 19–9 (CA19‐9) level: > 1000 u/mL versus ≤ 1000 U/mL; (iii) 18 fluorodeoxyglucose positron emission tomography/computed tomography ( 18 FDG PET/CT) scan result: equivocal versus negative (positive results were excluded from this analysis as they would not have proceeded to SL without additional workup); (iv) clinical stage: locally advanced versus early; (v) incidental GBC: yes versus no; (vi) tumor grade: moderate/poorly differentiated versus well differentiated. Results: The SL was incorporated into the diagnostic and management pathway of 330 GBC patients. SL was performed (i) as a staging prior to a planned radical cholecystectomy ( n = 210, 63.6%) and (ii) prior to initiating systemic therapy ( n = 120, 36.4%). The diagnostic yield of SL for detection of metastases over cross‐sectional imaging was 11.5% ( n = 38). Reasons for inoperability on laparotomy were metastatic 16b1 lymph node (LN) ( n = 19, 50%), locally unresectable disease ( n = 15, 39.5%), peritoneal metastasis ( n = 2, 5.3%), and liver metastasis ( n = 2, 5.3%). The reason for locally unresectable disease was right hepatic artery encasement at the porta hepatis. Regression analysis showed that the significant predictors for metastatic disease on SL were equivocal uptake on 18 FDG PET/CT scan ( p = < 0.001) and prior NACT ( p = 0.026). Conclusion: SL provides an incremental detection of radiologically occult metastasis in up to 11.5% patients. The study underscores the benefit of SL and suggests that it should be incorporated in the management of all GBC patients.
- 15 July 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (3) , e2500299
ConLymphNet: A Generalizable Region-Constrained Deep Learning Architecture for Precise Abdominal Lymph Node Segmentation Across Cancer Types.
Accurate identification and segmentation of abdominal lymph nodes on computed tomography (CT) is crucial for cancer staging and treatment planning but remains a challenging and time-consuming radiologic task. We developed and validated ConLymphNet, a deep learning-based approach for automated abdominal lymph node segmentation using vertebral landmarks as anatomic reference points to standardize the region of interest. We implemented a novel preprocessing pipeline incorporating vertebral landmark-based region selection followed by a 3D nnUNet segmentation model. The model was trained on 481 contrast-enhanced CT scans from patients with gallbladder cancer (GBC) and validated on external data sets including GBC (n = 54), public lymph node (n = 81), and multicancer data sets (n = 606). Performance was compared with three radiologists of varying experience levels. Interobserver agreement among radiologists and the incremental value of artificial intelligence (AI)-assisted reading were also assessed. To support reproducibility and future research, we also contribute 45 expert-verified lymph node segmentations for cases from public multicancer data sets. ConLymphNet achieved mean Dice coefficients of 0.696 ± 0.179, 0.631 ± 0.187, and 0.639 ± 0.176 and low false-positive rates of 0.78 ± 0.35, 0.81 ± 0.33, 0.93 ± 0.47/volume on internal cross-validation, external GBC, and public lymph node data sets, respectively. Performance varied by lymph node location (P = .0080) and size (P = .0444), with larger nodes yielding better results. The model's detection rate (89.6%) was comparable with experienced residents (89.2%) but with reduced processing time (28.7 ± 12.4s v 165.3 ± 47.8 s). AI assistance improved radiologists' performance significantly, particularly for less experienced readers (detection rate +20.2%, segmentation accuracy +13.0%, P < .001), while reducing false positives by 33.3%. ConLymphNet demonstrates reasonable performance across diverse cancer types and imaging protocols, offering segmentation accuracy comparable with radiologists with substantially faster processing times.
- 15 July 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (3) , e2500299
ConLymphNet: A Generalizable Region-Constrained Deep Learning Architecture for Precise Abdominal Lymph Node Segmentation Across Cancer Types.
Accurate identification and segmentation of abdominal lymph nodes on computed tomography (CT) is crucial for cancer staging and treatment planning but remains a challenging and time-consuming radiologic task. We developed and validated ConLymphNet, a deep learning-based approach for automated abdominal lymph node segmentation using vertebral landmarks as anatomic reference points to standardize the region of interest. We implemented a novel preprocessing pipeline incorporating vertebral landmark-based region selection followed by a 3D nnUNet segmentation model. The model was trained on 481 contrast-enhanced CT scans from patients with gallbladder cancer (GBC) and validated on external data sets including GBC (n = 54), public lymph node (n = 81), and multicancer data sets (n = 606). Performance was compared with three radiologists of varying experience levels. Interobserver agreement among radiologists and the incremental value of artificial intelligence (AI)-assisted reading were also assessed. To support reproducibility and future research, we also contribute 45 expert-verified lymph node segmentations for cases from public multicancer data sets. ConLymphNet achieved mean Dice coefficients of 0.696 ± 0.179, 0.631 ± 0.187, and 0.639 ± 0.176 and low false-positive rates of 0.78 ± 0.35, 0.81 ± 0.33, 0.93 ± 0.47/volume on internal cross-validation, external GBC, and public lymph node data sets, respectively. Performance varied by lymph node location (P = .0080) and size (P = .0444), with larger nodes yielding better results. The model's detection rate (89.6%) was comparable with experienced residents (89.2%) but with reduced processing time (28.7 ± 12.4s v 165.3 ± 47.8 s). AI assistance improved radiologists' performance significantly, particularly for less experienced readers (detection rate +20.2%, segmentation accuracy +13.0%, P < .001), while reducing false positives by 33.3%. ConLymphNet demonstrates reasonable performance across diverse cancer types and imaging protocols, offering segmentation accuracy comparable with radiologists with substantially faster processing times.
- 10 August 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (1) , 102401
Liver Resection for Hepatocellular Carcinoma: Recent Advances
- 10 August 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (1) , 102401
Liver Resection for Hepatocellular Carcinoma: Recent Advances
- Open Access
- 25 June 2023
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 13 (2) , 63-68
Pancreaticopleural Fistula: Revisiting a Rare Complication
Home Page right<div style="disp
- 25 June 2023
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 13 (2) , 63-68
Open AccessPancreaticopleural Fistula: Revisiting a Rare Complication
Home Page right<div style="disp
- Open Access
- 28 June 2022
- Published by Sciencedomain International in International Journal of Medical and Pharmaceutical Case Reports
- p. 1-5
Modified Clinical Practice of Sariva Kshara Sutra with Partial Fistulectomy in the Management of Bhagandara (Fistula-In-Ano)
Bhagandara is Ashta Mahagaroga (8 major disease) by Sushruta because of highest recurrence. Anorectal disorders are at peak, because to sedentary lifestyle and many other factors. 2 words Bhaga and Darana is bifurcation bhagandara, it is a common disease occurring in Anorectal region around the anus which may extends up to Genitalia. Pidika creation causes Bhagandara to develop, which is countered by opening up in the Guda Pradesh region with suffering and discharge. Kshara Sutra therapy is the one-of-a-kind, specific Parasurgical procedure that is employed in Fistula in Ano. Bhagandara is treated using a variety of modern scientific modalities, but to far no single modality has proven to be comprehensive for Fistula. The goal of the current study was to evaluate the modified way to treat fistula-in-ano with Sariva Kshara Sutra with partial fistulectomy. Case was taken from OPD/IPD of SHAH PILES FISTULA HOSPITAL, AHMEDABAD. CASE 1: - Age 31 yrs. Male Patient came to our hospital with complain of pain, swelling, discharge in scrotal to anterior anal canal (scrotal extension) treated with Sariva Kshara Sutra with partial fistulectomy considering its a best procedure in the treatment of Bhagandara preserving the Sphincter it treats the track.
- 28 June 2022
- Published by Sciencedomain International in International Journal of Medical and Pharmaceutical Case Reports
- p. 1-5
Open AccessModified Clinical Practice of Sariva Kshara Sutra with Partial Fistulectomy in the Management of Bhagandara (Fistula-In-Ano)
Bhagandara is Ashta Mahagaroga (8 major disease) by Sushruta because of highest recurrence. Anorectal disorders are at peak, because to sedentary lifestyle and many other factors. 2 words Bhaga and Darana is bifurcation bhagandara, it is a common disease occurring in Anorectal region around the anus which may extends up to Genitalia. Pidika creation causes Bhagandara to develop, which is countered by opening up in the Guda Pradesh region with suffering and discharge. Kshara Sutra therapy is the one-of-a-kind, specific Parasurgical procedure that is employed in Fistula in Ano. Bhagandara is treated using a variety of modern scientific modalities, but to far no single modality has proven to be comprehensive for Fistula. The goal of the current study was to evaluate the modified way to treat fistula-in-ano with Sariva Kshara Sutra with partial fistulectomy. Case was taken from OPD/IPD of SHAH PILES FISTULA HOSPITAL, AHMEDABAD. CASE 1: - Age 31 yrs. Male Patient came to our hospital with complain of pain, swelling, discharge in scrotal to anterior anal canal (scrotal extension) treated with Sariva Kshara Sutra with partial fistulectomy considering its a best procedure in the treatment of Bhagandara preserving the Sphincter it treats the track.